Contract Specifications

Instrument Type Underlying Expiry Date Option Type Strike Price Market Lot

Price Information

Last Price Today's Change Underlying value
 0.00   [0]  0.00
Open  0.00
Prev Close  0.00
Today's Range  0.00 - 0.00
Average Price  0.00
Buy(size)  0.00
Sell(size)  0.00

Turnover Open Interest Information

Volume Turnover Open Interest Change in OI %Change in OI
 0.00  0.00  0.00   [0.00]   [0]
FIIs trend in derivatives
Instruments Buy[Rs.Cr] Sell[Rs.Cr] Net Positions [Rs.Cr] Contracts ['000s] OI Value[Rs.Cr]
Index Futures 1,369.63 2,197.61 [827.98] 258.78 10,518.55
Index Options 10,515.80 9,607.38 908.42 1,493.47 60,433.08
Stock Futures 1,699.20 2,458.38 [759.18] 1,293.08 48,186.30
Stock Options 1,669.68 1,653.66 16.02 60.64 2,238.82

US takes aim at China in WTO, escalating stakes of trade war

India Infoline News Service Oct-19-2018

The WTO dispute settlement body will consider the US request at its October 29 meeting in Geneva.

Block deals on Friday, October 19, 2018

India Infoline News Service Oct-19-2018

Here are the most pertinent block/bulk deals that took place on the BSE and the NSE on Friday, October 19, 2018.

US stocks rally on boost from earnings; bonds decline

India Infoline News Service Oct-19-2018

The S&P 500 headed for its first weekly gain in a month as strong results from American Express, industrial heavyweight Honeywell, and consumer giant P&G bolstered confidence in the economy.

RBI extends FY19-20 gilts to bridge fiscal deficit

India Infoline News Service Oct-19-2018

The governments latest move might affect the countrys benchmark indices.

What rattled the Indian debt market and how?

India Infoline News Service Oct-19-2018

Many large lenders have blocked their usual credit lines to NBFC borrowers as they believe that such loans could pose bigger challenges in the future.

Govt. slaps anti-dumping duty on some steel products from China

India Infoline News Service Oct-19-2018

This move was mainly to protect domestic players against cheap imports from neighboring countries.

Indian Equities News

Biocon/Mylan receive positive CHMP opinion for Trastuzumab biosimilar

India Infoline News Service / 20:08, Oct 19, 2018

Biocon/Mylan have already received USFDA approval for Ogvri in the US while they are also expecting European approval for Fulphila.